DOI QR코드

DOI QR Code

Complementary and Alternative Medicine in Clinical Practice Guideline for Insomnia

  • Kwon, Chang-Young (Department of Clinical Korean Medicine, Graduate School of KyungHee University) ;
  • Suh, Hyo-Weon (Department of Clinical Korean Medicine, Graduate School of KyungHee University) ;
  • Choi, Eun-Ji (Department of Clinical Korean Medicine, Graduate School of KyungHee University) ;
  • Chung, Sun-Yong (Department of Korean Neuropsychiatry, Gangdong KyungHee University Hospital) ;
  • Kim, Jong-Woo (Department of Korean Neuropsychiatry, Gangdong KyungHee University Hospital)
  • 투고 : 2016.11.25
  • 심사 : 2016.12.29
  • 발행 : 2016.12.30

초록

Objectives: The aim of this review was to investigate whether evidence of complementary and alternative medicine (CAM) was reflected in clinical practice guidelines (CPGs) for insomnia based on relevant clinical trials. Methods: We conducted a systematic search on domestic and international CPG databases and medical databases. In addition, we conducted manual searches of relevant articles. Three authors independently searched and selected relevant studies; any disagreement was resolved by discussion. We extracted and analyzed the following data: published language, country, development group, participants, interventions, presence or absence of recommendations for CAM, level of evidence, grade of recommendation for CAM, and methods of development. Results: We identified 8,241 records from domestic and international databases, and 22 CPGs were included. Eleven of the 22 CPGs mentioned CAM interventions including herbal medicine, relaxation, acupuncture moxibustion, Tai Chi, meditation, hypnosis, biofeedback, Tuina, and external herbal medicine. However, most of the CPGs indicated 'no recommendation' or 'weak recommendation' for CAM interventions. Only Valeriana dageletiana Nakai and relaxation were considered to have experimental evidence. Valeriana dageletiana Nakai was recommended for improvement of sleep latency, sleep maintenance, total sleeping time, and sleep cycle. Relaxation was recommended as effective intervention for relieving physical and psychological arousal. Conclusions: Despite systematic reviews and randomized controlled trials on CAM for insomnia, most of the CPGs for insomnia did not reflect the evidence obtained. Further CPGs for insomnia should be developed by considering the current advanced studies in the field of CAM.

키워드

참고문헌

  1. Ishak WW, Bagot K, Thomas S, Magakian N, Bedwani D, Larson D, Brownstein A, Zaky C. Quality of life in patients suffering from insomnia. Innov Clin Neurosci. 2012; 9(10):13-26.
  2. Leger D, Bayon V. Societal costs of insomnia. Sleep Med Rev. 2010;14(6):379-89. https://doi.org/10.1016/j.smrv.2010.01.003
  3. Chung KF, Yeung WF, Ho FY, Yung KP, Yu YM, Kwok CW. Cross-cultural and comparative epidemiology of insomnia: the Diagnostic and statistical manual (DSM), International classification of diseases (ICD) and International classification of sleep disorders (ICSD). Sleep Med. 2015;16(4):477-82. https://doi.org/10.1016/j.sleep.2014.10.018
  4. Itani O, Kaneita Y, Munezawa T, Mishima K, Jike M, Nakagome S, Tokiya M, Ohida T. Nationwide epidemiological study of insomnia in Japan. Sleep Med. 2016; 25:130-8. https://doi.org/10.1016/j.sleep.2016.05.013
  5. Cho YW, Shin WC, Yun CH, Hong SB, Kim J, Earley CJ. Epidemiology of insomnia in korean adults: prevalence and associated factors. J Clin Neurol. 2009;5(1):20-3. https://doi.org/10.3988/jcn.2009.5.1.20
  6. Katz DA, McHorney CA. Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med. 1998; 158(10):1099-107. https://doi.org/10.1001/archinte.158.10.1099
  7. Smith MT, Neubauer DN. Cognitive behavior therapy for chronic insomnia. Clin Cornerstone. 2003;5(3):28. https://doi.org/10.1016/S1098-3597(03)90033-0
  8. Wilt TJ, MacDonald R, Brasure M, Olson CM, Carlyle M, Fuchs E, Khawaja IS, Diem S, Koffel E, Ouellette J, Butler M, Kane RL. Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians. Ann Intern Med. 2016;165(2):103-12. https://doi.org/10.7326/M15-1781
  9. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, Ospina M, Klassen TP, Witmans M. The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med. 2007;22(9): 1335-50. https://doi.org/10.1007/s11606-007-0251-z
  10. Holm KJ, Goa KL. Zolpidem: An update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia. Drugs. 2000;59:865-89. https://doi.org/10.2165/00003495-200059040-00014
  11. World Health Organization. Programme on Traditional Medicine. General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. Geneva: World Health Organization. 2000:1-80.
  12. Bertisch SM, Wells RE, Smith MT, McCarthy EP. Use of relaxation techniques and complementary and alternative medicine by American adults with insomnia symptoms: results from a national survey. J Clin Sleep Med. 2012; 8(6):681-91. https://doi.org/10.5664/jcsm.2264
  13. Ying Lan, Xi Wu, Hui-Juan Tan, Nan Wu, Jing-Jing Xing, Fu-Sheng Wu, Lei-Xiao Zhang, Fan-Rong Liang. Auricular acupuncture with seed or pellet attachments for primary insomnia: a systematic review and metaanalysis. BMC Complement Altern Med. 2015;15:103. https://doi.org/10.1186/s12906-015-0606-7
  14. Shergis JL, Ni X, Jackson ML, Zhang AL, Guo X, Li Y, Lu C, Xue CC. A systematic review of acupuncture for sleep quality in people with insomnia. Complement Ther Med. 2016;26:11-20. https://doi.org/10.1016/j.ctim.2016.02.007
  15. Lin YF, Liu ZD, Ma W, Shen WD. Hazards of insomnia and the effects of acupuncture treatment on insomnia. J Integr Med. 2016;14(3):174-86. https://doi.org/10.1016/S2095-4964(16)60248-0
  16. Liu L, Liu C, Wang Y, Wang P, Li Y, Li B. Herbal Medicine for Anxiety, Depression and Insomnia. Curr Neuropharmacol. 2015;13(4):481-93. https://doi.org/10.2174/1570159X1304150831122734
  17. Yeung WF, Chung KF, Poon MM, Ho FY, Zhang SP, Zhang ZJ, Ziea ET, Wong VT. Chinese herbal medicine for insomnia: a systematic review of randomized controlled trials. Sleep Med Rev. 2012;16(6):497-507. https://doi.org/10.1016/j.smrv.2011.12.005
  18. Taibi DM, Landis CA, Petry H, Vitiello MV. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev. 2007;11(3):209-30. https://doi.org/10.1016/j.smrv.2007.03.002
  19. Sarris J, Byrne GJ. A systematic review of insomnia and complementary medicine. Sleep Med Rev. 2011;15(2): 99-106. https://doi.org/10.1016/j.smrv.2010.04.001
  20. Choi MY, Kim NS, Sheen SS, Ji SM, Lee SJ, Kim JY, Park SH, You JH, Lyu DH. The status and dissemination plan of clinical practice guidelines in Korea. 2014. Available from: URL:http://www.neca.re.kr/center/paper/report_view.jsp?boardNo=GA&seq=146&q=63706167653d3226666c61673d3126626f6172644e6f3d474126736561726368436f6c3d2673656172636856616c3d2673656172636853596561723d2673656172636845596561723d
  21. Wieland LS, Manheimer E, Berman BM. Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med. 2011;17(2):50-9.
  22. Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines. Clinical Practice Guidelines We Can Trust. Washington (DC): National Academies Press. 2011:1-290.
  23. Wieland LS, Manheimer E, Berman BM. Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med. 2011;17(2):50-9.
  24. Doris Howell, Thomas K. Oliver, Sue Keller-Olaman et al. A Pan-Canadian practice guideline: prevention, screening, assessment, and treatment of sleep disturbances in adults with cancer. Support Care Cancer. 2013;21: 2695-706. https://doi.org/10.1007/s00520-013-1823-6
  25. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M. Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 2008;4(5): 487-504.
  26. Bloom HG, Ahmed I, Alessi CA, et al. Evidence-Based Recommendations for the Assessment and Management of Sleep Disorders in Older Persons. J Am Geriatr Soc. 2009;57(5):761-89. https://doi.org/10.1111/j.1532-5415.2009.02220.x
  27. Pinto Jr. LR, Alves RC, Caixeta E, et al. New guidelines for diagnosis and treatment of insomnia. Arq Neuropsiquiatr 2010;68(4):666-75. https://doi.org/10.1590/S0004-282X2010000400038
  28. Morgenthaler T, Kramer M, Alessi C, et al. Practice Parameters for the Psychological and Behavioral Treatment of Insomnia: An Update. Sleep 2006;29(11): 1415-9. https://doi.org/10.1093/sleep/29.11.1415
  29. University of Texas at Austin School of Nursing, Family Nurse Practitioner Program. Clinical guideline for the treatment of primary insomnia in middle-aged and older adults. Austin (TX): University of Texas at Austin, School of Nursing. 2014:1-28.
  30. Guideline Development Group on Sleep Disorders in Childhood and Adolescence in Primary Care. Clinical practice guideline on sleep disorders in childhood and adolescence in primary care. Madrid (Spain): Health Technology Assessment Unit, Lain Entralgo Agency, Ministry of Health, Social Services and Equality (Spain). 2011;1-288.
  31. American Medical Directors Association (AMDA). Sleep disorders. Columbia (MD): American Medical Directors Association (AMDA). 2006:1-38.
  32. Technology appraisal guidance. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. London: National Institute for Health and Care Excellence. 2004:1-35.
  33. Chinese Society of Neurology, Department of Sleep Disorders. Diagnosis and Treatment of Insomnia in Adult in China. Chin J Neurol. 2012;45(7):534-40. (Translated from 中华医学会神经病学分会睡眠障碍学组. 中国成人失眠诊断与治疗指南. 中华神经科杂誌. 2012;45(7):534-40.)
  34. Clinical Practice Guideline Working Group. Diagnosis to Management Guideline for Adult Primary Insomnia. Edmonton: Alberta Medical Association Toward Optimized Practice (TOP) Program. 2010:1-9.
  35. Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Ann Intern Med. 2016;165(2):125-33. https://doi.org/10.7326/M15-2175
  36. Group Health. Sleep Disorders Guideline. Washington: Group Health Cooperative. 2015:1-12.
  37. Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, Britton TC, Crowe C, Dijk DJ, Espie CA, Gringras P, Hajak G, Idzikowski C, Krystal AD, Nash JR, Selsick H, Sharpley AL, Wade AG. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. Journal of Psychopharmacology. 2010;24(11):1577-601. https://doi.org/10.1177/0269881110379307
  38. Ramakrishnan K, Csheid DC. Treatment Options for Insomnia. Am Fam Physician. 2007;76(4):517-26.
  39. Guidelines and Protocols Advisory Committee. Primary Care Management of Sleep Complaints in Adults. Victoria: Guidelines and Protocols Advisory Committee. 2004:1-6.
  40. Merseyside and Cheshire Palliative Care Network Audit Group. Guidelines For Managing Insomnia In Palliative Care. 2014. Available from: URL:http://www.nwcscnsenate.nhs.uk/files/3014/1217/3746/Insomnia_S_and_G_Final__Final_September_2014.pdf?PDFPATHWAY=PDF
  41. National Health Service (NHS) Drugs and Therapeutics Group. Guidelines For The Inpatient Treatment Of Insomnia In Adults. Version 4. 2015. Available from: URL:http://www.nwcscnsenate.nhs.uk/strategic-clinical-network/our-networks/palliative-and-end-life-care/audit-group/standards/
  42. National Health Service (NHS) Pharmacy Department Medicines Management Services. Clinical Guideline / Formulary Document Insomnia. 2015. Available from : URL:http://www.merseycare.nhs.uk/media/2121/insomnia-2014final.pdf
  43. Irish Sleep Society. Guidelines for the Assessment and Management of Patients with Sleep Disorders. 2010. Available from : URL:http://www.irishsleepsociety.org/index_htm_files/Practice%20Management%20Support%20Document.pdf
  44. Guideline working group for diagnosis and treatment of insomnia. Guideline for management and treatment of sleep disorders 2nd edition. Tokyo: Jiho. 2012:1-291. (Translated from 内山真. 睡眠障害の対応と治療ガイドライン第2版. 東京: じほう. 2012:1-291.)
  45. Health Labor Science Research Group.Japan Sleep Society Working Group. Clinical practice guideline for proper use of sleeping pills and drug withdrawal. 2013. Available from: URL:http://www.jssr.jp/data/pdf/suiminyakuguideline.pdf (Translated from 厚生労働科学研究班.日本睡眠学会ワ一キンググル一プ. 睡眠薬の適正な使⽤と休薬のための診療ガイドライン. 2013:1-37.)
  46. Chesson AL, McDowell WA, Littner M, et al. Practice parameters for the non-pharmacological treatment of chronic insomnia. Sleep. 1999;22:28-33.
  47. The ADAPTE Collaboration. The ADAPTE Precoess: Resource Toolkit for Guideline Adaptation. Version 2.0. 2009. Available from: http://www.g-i-n.net
  48. Fonnebo V, Grimsgaard S, Walach H, Ritenbaugh C, Norheim AJ, MacPherson H, Lewith G, Launso L, Koithan M, Falkenberg T, Boon H, Aickin M. Researching complementary and alternative treatments - the gatekeepers are not at home. BMC Med Res Methodol. 2007;7:7. https://doi.org/10.1186/1471-2288-7-7
  49. Neuendorf R, Wahbeh H, Chamine I, Yu J, Hutchison K, Oken BS. The Effects of Mind-Body Interventions on Sleep Quality: A Systematic Review. Evid Based Complement Alternat Med. 2015;2015:902708.

피인용 문헌

  1. 일개 보건소에서 시행한 불면증에 대한 한약치료의 효과분석 vol.28, pp.4, 2016, https://doi.org/10.7231/jon.2017.28.4.419
  2. Structural Mutations in the Organellar Genomes of Valeriana sambucifolia f. dageletiana (Nakai. ex Maekawa) Hara Show Dynamic Gene Transfer vol.22, pp.7, 2016, https://doi.org/10.3390/ijms22073770